营养与行为干预对代谢综合征患者坚持限能量地中海饮食的影响:PREDIMED-Plus随机临床试验的中期分析
该研究为正在进行的随机试验的初步探索性中期分析,纳入西班牙23个研究中心6874名55至75岁无心血管疾病的代谢综合征患者,随机分为鼓励限能量地中海饮食、促进体力活动并提供行为支持的干预组(n=3406)或鼓励不限能量地中海饮食的对照组(n=3468)。12个月时干预组er-MedDiet评分增加4.7(95%CI 4.6-4.8),对照组增加2.5(95%CI 2.3-2.6),组间差异2.2(95%CI 2.1-2.4;P<.001)。
要点
- 干预组12个月er-MedDiet评分增加4.7,对照组增加2.5,组间差异2.2(P<.001)。
- 干预措施包括鼓励限能量地中海饮食、促进体力活动及行为支持。
- 两组均免费获得特级初榨橄榄油(1 L/月)和坚果(125 g/月)。
核心结论
- 在正在进行的试验的初步分析中,与建议不限能量地中海饮食相比,鼓励限能量地中海饮食和体力活动的干预在12个月后使饮食依从性出现显著更大的增加。
- 需要进一步评估长期心血管效应。
研究设计与样本
- 正在进行的随机试验的初步探索性中期分析。
- 西班牙23个研究中心于2013年9月至2016年12月入组6874名55至75岁、有代谢综合征且无心血管疾病的男性和女性,最终数据收集于2019年3月。
- 参与者随机分为干预组(n=3406)和对照组(n=3468)。
主要发现
- 6874名随机参与者平均(SD)年龄65.0(4.9)岁,3406名(52%)为男性;6583名(96%)完成12个月随访并纳入主要分析。
- 干预组er-MedDiet评分基线均值(SD)为8.5(2.6),12个月为13.2(2.7),增加4.7(95%CI 4.6-4.8)。
- 对照组er-MedDiet评分基线均值(SD)为8.6(2.7),12个月为11.1(2.8),增加2.5(95%CI 2.3-2.6)。
- 组间差异为2.2(95%CI 2.1-2.4;P<.001)。
关键数值与推荐
- 主要结局为基于限能量地中海饮食(er-MedDiet)评分的12个月依从性变化,评分范围0-17,评分越高表示依从性越好,最小临床重要差异为1分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文为正在进行的试验的初步探索性中期分析。
- 需要进一步评估长期心血管效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: High-quality dietary patterns may help prevent chronic disease, but limited data exist from randomized trials about the effects of nutritional and behavioral interventions on dietary changes. OBJECTIVE: To assess the effect of a nutritional and physical activity education program on dietary quality. DESIGN, SETTING, AND PARTICIPANTS: Preliminary exploratory interim analysis of an ongoing randomized trial. In 23 research centers in Spain, 6874 men and women aged 55 to 75 years with metabolic syndrome and no cardiovascular disease were enrolled in the trial between September 2013 and December 2016, with final data collection in March 2019. INTERVENTIONS: Participants were randomized to an intervention group that encouraged an energy-reduced Mediterranean diet, promoted physical activity, and provided behavioral support (n = 3406) or to a control group that encouraged an energy-unrestricted Mediterranean diet (n = 3468). All participants received allotments of extra-virgin olive oil (1 L/mo) and nuts (125 g/mo) for free. MAIN OUTCOMES AND MEASURES: The primary outcome was 12-month change in adherence based on the energy-reduced Mediterranean diet (er-MedDiet) score (range, 0-17; higher scores indicate greater adherence; minimal clinically important difference, 1 point). RESULTS: Among 6874 randomized participants (mean [SD] age, 65.0 [4.9] years; 3406 [52%] men), 6583 (96%) completed the 12-month follow-up and were included in the main analysis. The mean (SD) er-MedDiet score was 8.5 (2.6) at baseline and 13.2 (2.7) at 12 months in the intervention group (increase, 4.7 [95% CI, 4.6-4.8]) and 8.6 (2.7) at baseline and 11.1 (2.8) at 12 months in the control group (increase, 2.5 [95% CI, 2.3-2.6]) (between-group difference, 2.2 [95% CI, 2.1-2.4]; P < .001). CONCLUSIONS AND RELEVANCE: In this preliminary analysis of an ongoing trial, an intervention that encouraged an energy-reduced Mediterranean diet and physical activity, compared with advice to follow an energy-unrestricted Mediterranean diet, resulted in a significantly greater increase in diet adherence after 12 months. Further evaluation of long-term cardiovascular effects is needed. TRIAL REGISTRATION: isrctn.com Identifier: ISRCTN89898870.
引用
- Sayón-Orea C, Razquin C, Bulló M, et al. Effect of a Nutritional and Behavioral Intervention on Energy-Reduced Mediterranean Diet Adherence Among Patients With Metabolic Syndrome: Interim Analysis of the PREDIMED-Plus Randomized Clinical Trial. JAMA. 2019. PMID: 31613346. doi:10.1001/jama.2019.14630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。